LA Private

November 2024

Nvidia surpasses expectations; Wall St mixed; ASX to open higher

US markets showed a mixed performance overnight, with the Dow Jones rallying late in the session, closing up 0.3 per cent, while the S&P 500 finished flat. The Nasdaq, however, ended slightly lower, down 0.1 per cent. A key driver of the overnight action was the anticipation surrounding Nvidia’s quarterly earnings and outlook. Nvidia’s shares

Nvidia surpasses expectations; Wall St mixed; ASX to open higher Read More »

Pinnacle invests $143m in two international firms

Pinnacle Investment Management (ASX:PNI) has announced investments in two international asset managers—VSS Capital Partners (VSS) and Pacific Asset Management (PAM). Together, the investments total $143m. The acquisitions aim to strengthen Pinnacle’s foothold in private capital and international markets. In VSS, Pinnacle now has a 22.5% stake. The company is a US-based structured capital firm with

Pinnacle invests $143m in two international firms Read More »

Injecting hope: Clinuvel eyes higher SCENESSE usage in Europe

Clinuvel Pharmaceuticals (ASX:CUV) has entered discussions with the European Medicines Agency (EMA) to increase the recommended maximum annual dosage of SCENESSE (afamelanotide 16mg) for patients with erythropoietic protoporphyria (EPP) from four to six doses. This change would harmonise European guidelines with those in other regions, including the United States, enabling year-round treatment for patients. EPP

Injecting hope: Clinuvel eyes higher SCENESSE usage in Europe Read More »